MAS vs TXG · P/E 18, rev $7.83B vs rev $610.8M
Masco Corporation (MAS) versus 10X Genomics Inc (TXG) — a side-by-side from cached financials, not a winner call.
Masco Corporation (MAS) is a building products & equipment company listed on US.
10X Genomics Inc (TXG) is a health information services company listed on NASDAQ.
Latest reported MAS revenue for 2024-12-31 was $7.83B. Net income was $874.0M. Revenue was down 1.7% from 2023-12-31 to 2024-12-31. MAS currently screens at market cap $14.00B and trailing P/E 18.1.
Latest reported TXG revenue for 2024-12-31 was $610.8M. Net income was -$182.6M. Revenue was down 1.3% from 2023-12-31 to 2024-12-31. TXG currently screens at market cap $4.08B.
MAS currently screens at market cap $14.00B and trailing P/E 18.1. TXG currently screens at market cap $4.08B.
Not investment advice. Open the MAS and TXG stock pages for the full models.
Not investment advice.